Primary cutaneous aspergillosis [5]

Indian Journal of Dermatology, Venereology and Leprology

Volumn 71, Issue 2, 2005, Pages 133-134

  Prasad, P V S ^a,b   Babu, A ^a   Kaviarasan, P K ^a   Anandhi, C ^a   Viswanathan, P ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b Sivapuri Post   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ANAMNESIS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FUNGAL DETECTION; FUNGUS IDENTIFICATION; GENERAL CONDITION IMPROVEMENT; HISTOPATHOLOGY; HUMAN; LETTER; MEDICAL EXAMINATION; SKIN BIOPSY; TISSUE SECTION; TREATMENT OUTCOME;

EID: 22144469435     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.14006     Document Type: Letter

References (6)

1. John PU, Shadomy HJ. Deep fungal infections. In: Dermatology in general medicine. Fitzpatrick TB, Eisen AZ, Wolff K, et al editors. 3rd Ed. New York: McGraw - Hill; 1987. p. 2266-8.
2. Longley BJ. Fungal diseases. In: Lever′s Histopathology of the Skin, David Elder, Elenitsas R, and Jaworsky C, et al editors. 8th Ed. Philadelphia: Lippincott Raven; 1997. p. 525-6.
3. Clancy CJ, Nguyen MH. In vitro efficacy and fungicidal activity of voriconazole against aspergillus and Fusarium species. Euro J Clin Microbiol Infect Dis 1998;17:573-5.
4. Chandrasekar PH, Manavathu E. Voriconazole: A second generation triazole. Drugs Today 2001;37:135-48.
5. Galimberti R, Kowalczuk A, Hidalgo PI, Gonzalez RM, Flores V. Cutaneous Aspergillosis: A report of six cases. Br J Dermatol 1998;139:522-6.
6. Roberts SO, Hay RJ, Mackenzie DW. A clinician′s guide to fungal disease. New York: Marcel Dekker; 1984. p. 162-70.